MTHFR and neoplasm: The decrease at global DNA methylation levels observed among rGBM patients with TT genotype would suggest worse prognosis for such patients, since this mutated genotype is associated to a drastic MTHFR loss of enzymatic functionality, impacting on decreasing the global DNA methylation scores, which is described as a marker of genesis and tumor progression [3, 4, 50, 51].